BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 11
• 12
• 13
• 14
• 15
• 16
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29

• Cayman Chemical Introduces LipidLaunch™, Expands Portfolio of Lipid Nanoparticle Research Tools to Support Advances in RNA Therapies

  Cayman Chemical, a leading supplier of research tools for lipid nanoparticles (LNPs), announced today the introduction of LipidLaunch™ research-ready LNPs and reagent kits.

  February 20, 2024

   · 

  2 min read
• MediThinQ Marks Milestone as First Asian Startup to Globally Launch XR Surgical Displays, Securing Key Partnerships and Multimillion-Dollar Investment

  MediThinQ, a pioneering Korean startup specialising in extended reality wearable displays for surgery, is making waves as the first Asian startup to globally launch XR surgical displays.

  February 20, 2024

   · 

  3 min read
• Philips delivers strong ESG performance in 2023

  Royal Philips, a global leader in health technology, has relentlessly focused on further improving its Environmental, Social, and Governance performance in 2023.

  February 20, 2024

   · 

  6 min read
• Invitation to Presentation of BioInvent’s Year-end Report 2023

  BioInvent International AB invites investors, analysts, and the press to a presentation of the year-end report 2023 at 2:00 pm on February 22.

  February 20, 2024

   · 

  2 min read
• RetinAI Discovery® platform and AI tools launched to improve decision workflows, referrals and patient management in Clinics for Ophthalmologists and Optometrists

  Ikerian AG and RetinAI Inc. US (“RetinAI”), a leader in developing software solutions for image processing and artificial intelligence (AI) in Ophthalmology

  February 20, 2024

   · 

  3 min read
• Business

  IDEAYA Biosciences, Inc. Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update

  IDEAYA Biosciences, Inc., a precision medicine oncology company committed to the discovery and development of targeted therapeutics, provided a business update and announced financial results for the quarter and full-year ended December 31, 2023.

  February 20, 2024

   · 

  20 min read
• Genetown

  KalVista Pharmaceuticals Awarded UK Innovation Passport for Sebetralstat

  KalVista Pharmaceuticals, Inc. announced the UK Medicines and Healthcare products Regulatory Agency has awarded the Innovation Passport for sebetralstat, an investigational novel, oral plasma kallikrein inhibitor for the on-demand treatment of hereditary angioedema.

  February 20, 2024

   · 

  4 min read
• Job Trends

  FDA Grants Priority Review to Merck’s Application for KEYTRUDA® (pembrolizumab) Plus Chemotherapy as Treatment for Primary Advanced or Recurrent Endometrial Carcinoma

  Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced the U.S. Food and Drug Administration (FDA) has accepted for priority review a new supplemental Biologics License Application (sBLA) seeking approval for KEYTRUDA.

  February 20, 2024

   · 

  74 min read
• Business

  Enpro Reports Fourth Quarter and Full Year 2023 Results, Introduces 2024 Guidance Fourth Quarter Results Full Year 2023 Highlights

  Enpro Inc. (NYSE: NPO) today announced its financial results for the three months and year ended December 31, 2023.

  February 20, 2024

   · 

  35 min read
• Business

  Medtronic reports third quarter fiscal 2024 financial results

  Medtronic plc (NYSE:MDT) today announced financial results for its third quarter (Q3) of fiscal year 2024 (FY24), which ended January 26, 2024.

  February 20, 2024

   · 

  32 min read